Kd. Kroncke et al., NITRIC-OXIDE GENERATION DURING CELLULAR METABOLIZATION OF THE DIABETOGENIC N-METHYL-N-NITROSO-UREA STREPTOZOTOZIN CONTRIBUTES TO ISLET-CELLDNA-DAMAGE, Biological chemistry Hoppe-Seyler, 376(3), 1995, pp. 179-185
The N-methyl-N-nitroso-urea streptozotocin is an antibiotic with diabe
togenic, carcinogenic and antitumor activity thought to act via alkyla
tion of DNA and proteins. Evidence points to a release of bioactive ni
tric oxide (NO) from streptozotocin as an additional cytotoxic activit
y of this drug. Here we show by EPR spectroscopy, that NO is not gener
ated during spontaneous decay of streptozotocin but that its metaboliz
ation in rat hepatocytes and pancreatic islet cells yields NO. This NO
formation is not due to a NO synthase (NOS) activity since NO formati
on in hepatocytes in the presence of streptozotocin is not blocked by
the NOS inhibitor N-G-methyl-L-arginine. By iNOS-specific RT-PCR no po
sitive signal for specific m RNA presence was obtained in streptozotoc
in-treated cells, proving that iNOS activity was not induced during ce
ll isolation procedures and did not account for the NO release, Furthe
rmore, early DNA-strand breaks induced either by SZ or by the NO donor
nitroprusside were both significantly reduced in the presence of an i
ntracellular NO scavenger. In contrast, DNA damage found after incubat
ion with the purely alkylating agent methyl-methanesulfonate was not i
nhibited by the NO trap, These results prove that intracellular format
ion of NO occurs during degradation of SZ within cells. This NO appear
s to contribute significantly to streptozotocin-induced cytotoxicity.